Results 31 to 40 of about 747,115 (360)

Ultrasonography for diagnosis of alcoholic cirrhosis in people with alcoholic liver disease [PDF]

, 2016
BACKGROUND: Heavy alcohol consumption causes alcoholic liver disease and is a causal factor of many types of liver injuries and concomitant diseases. It is a true systemic disease that may damage the digestive tract, the nervous system, the heart and ...
Casazza, G, Gluud, C, Ivashkin, VT, Liusina, E, Nikolova, D, Pavlov, CS, Semenistaia, M, Tsochatzis, E   +7 more
core   +1 more source

Liver Transplantation for Alcoholic Liver Disease: A Consideration of Reasons For and Against [PDF]

, 1989
Orthotopic liver transplantation is a clinical procedure that has been accepted widely as the treatment of choice for individuals with advanced chronic liver disease.
Dindzans, VJ, Gavaler, JS, Gordon, RD, Iwatsuki, S, Makowka, L, Starzl, TE, Tarter, RE, Todo, S, Tzakis, A, Van Thiel, DH   +9 more
core   +1 more source

A lupine (Lupinus angustifolious L.) peptide prevents non-alcoholic fatty liver disease in high-fat-diet-induced obese mice [PDF]

, 2020
Bioactive peptides are related to the prevention and treatment of many diseases. GPETAFLR is an octapeptide that has been isolated from lupine (Lupinus angustifolius L.) and shows anti-inflammatory properties.
Claro Cala, Carmen María, Grao Cruces, Elena, Lemus Conejo, Ana, Millán, Francisco, Millán-Linares, María del Carmen, Montserrat de la Paz, Sergio, Pedroche, Justo, Toscano, Rocío, Varela Pérez, Lourdes María   +8 more
core   +1 more source

Randomised clinical trial: semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non‐alcoholic fatty liver disease assessed by magnetic resonance imaging

Alimentary Pharmacology and Therapeutics, 2021
Glucagon‐like peptide‐1 receptor agonists may be a treatment option in patients with non‐alcoholic fatty liver disease (NAFLD).
A. Flint, G. Andersen, P. Hockings, L. Johansson, A. Morsing, Mads Sundby Palle, T. Vogl, R. Loomba, L. Plum-Mörschel   +8 more
semanticscholar   +1 more source

Alcoholic Liver Disease [PDF]

, 1993
Relationship between ethanol drinking and organs injury was reviewed and special emphasis was put on alcoholic liver disease. Consumption of alcoholic beverage expressed as ethanol per capita of adult in Japan increased 2.1 times in these 25 years and it
Endo, Hiroshi, Mori, Shuji, Nakata, Yasunari, Ohta, Takeo, Okamoto, Motoi   +4 more
core   +1 more source

Relationship between body composition and the histology of non‐alcoholic fatty liver disease: a cross‐sectional study

BMC Gastroenterology, 2021
Background Causes of non-alcoholic fatty liver disease and its progression include visceral fat accumulation and loss of muscle mass; however, which of the two phenomena is more critical is unclear.
Teruki Miyake, Masumi Miyazaki, Osamu Yoshida, Sayaka Kanzaki, Hironobu Nakaguchi, Yoshiko Nakamura, Takao Watanabe, Yasunori Yamamoto, Yohei Koizumi, Yoshio Tokumoto, Masashi Hirooka, Shinya Furukawa, Eiji Takeshita, Teru Kumagi, Yoshio Ikeda, Masanori Abe, Kumiko Toshimitsu, Bunzo Matsuura, Yoichi Hiasa   +18 more
doaj   +1 more source

ALCOHOLIC LIVER DISEASE: ISSUES OF ETIOLOGY AND THE IMPACT OF RISK FACTORS (LITERATURE REVIEW)

Байкальский медицинский журнал, 2023
Alcohol consumption is one of the main causes leading to chronic liver disease. Alcoholic liver disease is a set of cascading events, consisting first of alcoholic hepatic steatosis and then mainly through alcoholic steatohepatitis, leading to cirrhosis ...
Daria A. Stepanenko, Tatyana V. Goma, Natalia M. Kozlova   +2 more
doaj   +1 more source

Endocannabinoid receptor blockade increases hepatocyte growth factor and reduces insulin levels in obese women with polycystic ovary syndrome [PDF]

, 2016
There is evidence from animal and in-vitro studies that activation of the endocannabinoid system (EC) through cannabinoid receptor 1 (CB-1) is associated with liver injury, inflammation and hepatocellular carcinoma.1 Data suggests endogenous cannabinoids
Ahmed, Lina, Atkin, Stephen L., Coady, Anne-Marie, Dakroury, Youssra, Elshewehy, Abeer M. M., Kilpatrick, Eric S., Sathyapalan, Thozhukat   +6 more
core   +1 more source

Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease

Cellular and Molecular Life Sciences, 2018
Non-alcoholic fatty liver disease (NAFLD) is currently the world’s most common liver disease, estimated to affect up to one-fourth of the population.
D. H. Ipsen, J. Lykkesfeldt, P. Tveden-Nyborg   +2 more
semanticscholar   +1 more source

Roles of Ceramides in Non-Alcoholic Fatty Liver Disease

Journal of Clinical Medicine, 2021
Non-alcoholic fatty liver disease is one of the most common chronic liver diseases, ranging from simple steatosis to steatohepatitis, fibrosis, and cirrhosis. Its prevalence is rapidly increasing and presently affects around 25% of the general population
E. Hajduch, Floriane Lachkar, P. Ferré, F. Foufelle   +3 more
semanticscholar   +1 more source